Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Transplant International : Official Journal of the European Society for Organ Transplantation|May 22, 2023
Pregnancy Complications and Impact on Kidney Allograft After Kidney Transplantation in IgA NephropathyRikako Oki, Kohei Unagami, Jun Kakogawa, et al.
Nephrology (Carlton, Vic.)|June 3, 2015
A case of recurrent focal segmental glomerulosclerosis after kidney transplantation associated with variant conversion in the Columbia classificationKohei Unagami, Kunio Kawanishi, Tomokazu Shimizu, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risksRyoichi Maenosono, Kohei Unagami, Rikako Oki, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 13, 2004
[The clinical efficacy of Bladder Chek NMP22 in urothelial cancer]Takashi Yokoyama, Rumi Sekigawa, Tetsuo Hayashi, et al.
The Lancet Regional Health. Southeast Asia|February 16, 2024
Deceased donor kidney transplant policies in Asia - implications on practice and recommendations for the futureJackson Tan, Muhammad Abdul Mabood Khalil, Terence Kee, et al.
Nephron|November 25, 2020
Chronic Active Antibody-Mediated Rejection with Linear IgG Deposition on Glomerular Capillaries in a Kidney Transplant RecipientKenichiro Miura, Yoko Shirai, Naoto Kaneko, et al.
Targeted Oncology|June 26, 2021
Prognostic Impact of Early Treatment Interruption of Nivolumab Plus Ipilimumab Due to Immune-Related Adverse Events as First-Line Therapy for Metastatic Renal Cell Carcinoma: A Multi-Institution Retrospective StudyHiroki Ishihara, Yuki Nemoto, Kazutaka Nakamura, et al.
In Vivo (Athens, Greece)|August 28, 2025
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 TrialKazutaka Nakamura, Yuki Kobari, Yudai Ishiyama, et al.
Transplant Immunology|December 30, 2022
The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19Ken Arimura, Etsuko Tagaya, Ken Kikuchi, et al.
Pathology International|September 12, 2019
Fate of full-house immunofluorescence staining in renal allograft: A case reportAnri Sawada, Kohei Unagami, Shigeru Horita, et al.
Pageof 30